Apple | Mobile |
---|---|
Business Dev & Design Entertainment | Social Media Tech Web Video |
Apple | Mobile |
---|---|
Business Dev & Design Entertainment | Social Media Tech Web Video |
Develops intra and extracorporeal gas exchange devices.
Year Established: | 1997 |
Funding: | |
Address: | Pittsburgh, PA 15219 |
Telephone: | 2147483647 |
Mobile: | |
Fax: | 412-697-3376 |
Mail: | info@alung.com |
Company URL: | http://www.alung.com |
Careers
ALung is a pioneer in the development of respiratory assist technologies that provide a superior alternative to traditional, invasive respiratory support.
ALung has two exciting new opportunities as we continue to expand our dynamic team. If you are interested in joining our fast-paced and innovative team environment to contribute toward the success and continued growth of ALung Technologies please review the opportunities listed below.
We offer a competitive compensation and benefits package that includes medical, dental, vision, EAP plans, life, STD, LTD and 401k plan.
ALung is an equal opportunity employer that does not discriminate on the basis of race, color, religion, gender, national origin, age, military service eligibility, veteran status, sexual orientation, marital status, disability, or any other protected class.
If you are interested and qualified please indicate the position that you are submitting your resume for as well as your salary requirements to: careers@alung.com
Innovation Works, Inc.,Spring Capital Asia, Ltd.
Peter M. DeComo, the Chairman and Chief Executive Officer, recently founded and shepherded Renal Solutions to a $200 million acquisition by Fresenius Medical Care in late 2007. In addition, he is a registered respiratory therapist, and has an extensive background in extracorporeal therapies.
Nick Kuhn, Chief Operating Officer, has extensive experience in the respiratory medical device industry, having held senior sales, marketing and operational positions at Baxter, Resmed, and Nellcor Puritan Bennett.
Frank J. Falcione, VP Regulatory Affairs/Quality Assurance and Manufacturing, has extensive experience in FDA submissions and ISO quality system implementation. He has held senior positions in these capacities at CHS Business Associates, Emerson and Chiron Diagnostics.
Burt Ochs, Director of Engineering, has a multi-disciplinary background in physiology, electrical, software and mechanical engineering. He has held senior positions at TransMedics and ABIOMED.
Scott Morley, Director of Clinical and Market Development, has an extensive background in biomedical engineering and clinical affairs. He previously served as the engineering project manager in charge of Hemolung development. He has been with the Company since 2003.
Advisors
Nausherwan Burki, M.D., Ph.D., Medical Director and Chairman of the Medical Advisory Board, is Professor, Department of Medicine, Division of Pulmonary & Critical Care Medicine at the University of Connecticut Health Center, Farmington, Connecticut. As a physician-scientist with expertise in both the physiology and treatment of lung disease, Dr. Burki directs the Company's clinical research programs.
William Federspiel, Ph.D., Chairman of the Scientific Advisory Board and co-founder, is the Director of the Medical Devices Laboratory, McGowan Institute for Regenerative Medicine, University of Pittsburgh where he is a William Kepler Whiteford Professor of Bioengineering, Chemical Engineering, and Critical Care Medicine.